Dr. Mitchell Jacobson, M.D
NPI: 1346254539
Total Payments
$39,582
2024 Payments
$1,725
Companies
65
Transactions
855
Medicare Patients
8,427
Medicare Billing
$403,194
Payment Breakdown by Category
Other$16,664 (42.1%)
Food & Beverage$15,110 (38.2%)
Consulting$5,187 (13.1%)
Travel$2,507 (6.3%)
Education$113.95 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,664 | 12 | 42.1% |
| Food and Beverage | $15,110 | 818 | 38.2% |
| Consulting Fee | $5,187 | 5 | 13.1% |
| Travel and Lodging | $2,507 | 10 | 6.3% |
| Education | $113.95 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18,523 | 47 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $5,818 | 49 | $0 (2024) |
| Lilly USA, LLC | $3,516 | 142 | $0 (2024) |
| Novo Nordisk Inc | $2,552 | 189 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,194 | 71 | $0 (2022) |
| Tandem Diabetes Care, Inc. | $1,129 | 12 | $0 (2024) |
| Insulet Corporation | $814.63 | 28 | $0 (2024) |
| Amgen Inc. | $549.02 | 30 | $0 (2024) |
| Dexcom, Inc. | $492.74 | 14 | $0 (2024) |
| ABBVIE INC. | $458.30 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,725 | 84 | Novo Nordisk Inc ($368.25) |
| 2023 | $1,574 | 93 | Lilly USA, LLC ($385.94) |
| 2022 | $1,619 | 96 | Novo Nordisk Inc ($354.55) |
| 2021 | $1,685 | 105 | Novo Nordisk Inc ($387.70) |
| 2020 | $900.39 | 50 | AstraZeneca Pharmaceuticals LP ($149.74) |
| 2019 | $2,390 | 143 | Novo Nordisk Inc ($299.80) |
| 2018 | $16,899 | 144 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,277) |
| 2017 | $12,789 | 140 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,980) |
All Payment Transactions
855 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $23.32 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 12/02/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $41.42 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Bone Health | ||||||
| 10/23/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Endocrinology | ||||||
| 10/21/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: Durable Pump | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Endocrinology | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $25.32 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $26.04 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,437 | 4,963 | $334,414 | $118,308 |
| 2022 | 27 | 2,611 | 5,015 | $347,123 | $123,428 |
| 2021 | 24 | 1,721 | 3,906 | $273,670 | $97,423 |
| 2020 | 27 | 1,658 | 3,130 | $208,927 | $64,035 |
Total Patients
8,427
Total Services
17,014
Medicare Billing
$403,194
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 587 | $99,790 | $54,704 | 54.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 78 | $17,940 | $10,054 | 56.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 194 | 418 | $24,244 | $5,484 | 22.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 195 | 494 | $49,400 | $5,113 | 10.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 205 | 553 | $7,742 | $4,645 | 60.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 144 | 263 | $11,835 | $4,329 | 36.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 62 | 143 | $10,725 | $3,803 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $11,200 | $3,640 | 32.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 164 | 372 | $11,904 | $3,541 | 29.8% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 181 | 439 | $9,658 | $3,099 | 32.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 92 | 101 | $15,150 | $2,930 | 19.3% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 185 | 454 | $13,166 | $2,897 | 22.0% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 90 | 187 | $6,358 | $2,599 | 40.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 24 | 25 | $6,250 | $2,250 | 36.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 31 | 52 | $6,240 | $2,103 | 33.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 115 | 236 | $8,024 | $2,086 | 26.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 99 | 118 | $2,950 | $897.98 | 30.4% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 17 | 32 | $2,400 | $809.28 | 33.7% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 16 | 31 | $2,635 | $660.30 | 25.1% |
| 84378 | Carbohydrate analysis, single quantitative | Office | 2023 | 36 | 49 | $4,165 | $553.70 | 13.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 77 | 88 | $2,552 | $447.04 | 17.5% |
| 84681 | C-peptide (protein) level | Office | 2023 | 20 | 20 | $2,120 | $407.80 | 19.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 15 | 19 | $1,615 | $342.38 | 21.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 52 | 56 | $3,416 | $316.96 | 9.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 15 | 16 | $1,280 | $236.48 | 18.5% |
About Dr. Mitchell Jacobson, M.D
Dr. Mitchell Jacobson, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Ft. Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346254539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Jacobson, M.D has received a total of $39,582 in payments from pharmaceutical and medical device companies, with $1,725 received in 2024. These payments were reported across 855 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,664).
As a Medicare-enrolled provider, Jacobson has provided services to 8,427 Medicare beneficiaries, totaling 17,014 services with total Medicare billing of $403,194. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Ft. Lauderdale, FL
- Active Since 07/27/2006
- Last Updated 03/09/2020
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1346254539
Products in Payments
- JARDIANCE (Drug) $20,202
- SOTAGLIFLOZIN (Drug) $4,893
- Ozempic (Drug) $1,271
- FARXIGA (Drug) $1,083
- t-slim insulin pump (Device) $1,011
- Omnipod (Device) $814.63
- Rybelsus (Drug) $448.38
- TRULICITY (Drug) $395.00
- Victoza (Drug) $362.21
- LYUMJEV (Drug) $339.45
- AFREZZA (Drug) $320.83
- HUMULIN (Drug) $316.52
- MOUNJARO (Drug) $251.98
- Synthroid (Drug) $248.46
- Repatha (Biological) $247.73
- TRADJENTA (Drug) $242.37
- UNITHROID (Drug) $222.96
- Dexcom CGM (Device) $213.60
- SOLIQUA 100/33 (Biological) $208.03
- Dexcom G6 Transmitter (Medical Supply) $192.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.